Pfizer, Merck and Novartis to shut manufacturing sites as hurricane looms
Major pharmaceutical companies and CMOs in the US have announced emergency contingency plans, including facility closures and the relocation of drug products, as Hurricane Florence approaches southeastern shores. A hurricane due to hit southeastern states in the US this week has prompted President Trump to declare a an emergency in the state of North Carolina.
from Biotech News
0 Comments